Our COVID-19 Research
Cochrane Response is part of the operating team of the COVID-19 living systematic review and network meta-analysis initiatiative. COVID-NMA is an international initiative working in conjunction with the World Health Organization (WHO), led by a team of researchers from Cochrane and other institutions (Université de Paris, Inserm, CNRS, Centre for Evidence-Based Medicine Odense (CEBMO), University of Southern Denmark, Odense University Hospital, Epistemonkos Foundation, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, University of Milan).
Rapid reviews on treatments for COVID-19: Hydroxychloroquine
Rapid reviews on treatments for COVID-19: Lopinavir/ritonavir
Changing physical environments to change behaviours to reduce transmission of SARS-CoV-2
Commissioned by the UK Innovation and Research, Economic and Social Research Council; Scoping review and rapid review: Encouraging behaviour change to reduce COVID-19 transmission: A summary of two rapid evidence reviews
COVID-19 DTA rapid reviews
Contributing towards updates of the following Cochrane rapid reviews: